PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

NCT05387954 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

792

Enrollment

OTHER

Sponsor class

Conditions

Cryptogenic Ischemic Stroke
Patent Foramen Ovale

Interventions

PROCEDURE: Transcatheter PFO closure
DRUG: Oral Anticoagulant, Direct-Acting
DRUG: Antiplatelet therapy

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]